{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:14:58Z","timestamp":1790716498038,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006033.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:00:00Z","timestamp":1403568000000}}],"reference-count":77,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006033.pub5","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T19:02:24Z","timestamp":1403636544000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Steroidal contraceptives: effect on bone fractures in women"],"prefix":"10.1002","volume":"2014","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[{"name":"FHI 360; Clinical Sciences; 359 Blackwell St, Suite 200 Durham North Carolina USA 27701"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[{"name":"University of North Carolina, School of Medicine; Obstetrics and Gynecology; CB#7570 Chapel Hill North Carolina USA 27599-7570"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[{"name":"FHI 360 and UNC School of Medicine; Quantitative Sciences; 359 Blackwell Street, Suite 200 Suite 200 Durham North Carolina USA 27701"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention; Division of Reproductive Health; MS K-34, 4770 Buford Highway, NE Atlanta Georgia USA 30341"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Chen","sequence":"additional","affiliation":[{"name":"FHI 360; Division of Biostatistics; 359 Blackwell St, Suite 200 Durham, NC North Carolina USA 27709"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,24]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD006033.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-4755-4-11","article-title":"A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants","volume":"4","author":"Monteiro-Dantas","year":"2007","journal-title":"Reproductive Health"},{"issue":"5","key":"10.1002\/14651858.CD006033.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","article-title":"Effects of hormonal contraception on bone mineral density after 24 months of use","volume":"103","author":"Berenson","year":"2004","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD006033.pub5-BIB0004|cit4","first-page":"576","article-title":"A prospective, controlled study of the effects of hormonal contraception on bone mineral density","volume":"98","author":"Berenson","year":"2001","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD006033.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-11-1047","article-title":"Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence","volume":"166","author":"Cibula","year":"2012","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajog.2004.07.041","article-title":"Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception","volume":"192","author":"Cromer","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/jc.2002-020874","article-title":"A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate","volume":"88","author":"Cundy","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(99)00080-3","article-title":"Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism","volume":"60","author":"Di","year":"1999","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2003.10.002","article-title":"A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 \u03bcg or 30 \u03bcg ethinylestradiol in combination with levonorgestrel on bone mineral density","volume":"69","author":"Endrikat","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD006033.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.contraception.2012.01.009","article-title":"Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women","volume":"86","author":"Gai","year":"2012","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2008.01.016","article-title":"Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"78","author":"Gargano","year":"2008","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD006033.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2006.06.005","article-title":"Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles","volume":"74","author":"Hartard","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.contraception.2009.09.011","article-title":"Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study","volume":"81","author":"Massaro","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0010-7824(95)00121-P","article-title":"Differential effects on bone density of progestogen-only methods for contraception in premenopausal women","volume":"52","author":"Naessen","year":"1995","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD006033.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0010-7824(03)00025-8","article-title":"Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"67","author":"Nappi","year":"2003","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000148344.26475.fc","article-title":"Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density","volume":"105","author":"Nappi","year":"2005","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD006033.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(00)00104-9","article-title":"Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women","volume":"61","author":"Paoletti","year":"2000","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD006033.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13625187.2011.556761","article-title":"Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use","volume":"16","author":"Rad","year":"2011","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"6","key":"10.1002\/14651858.CD006033.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2009.05.128","article-title":"Continuous, daily levonorgestrel\/ethinyl estradiol vs. 21-day,cyclic levonorgestrel\/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial","volume":"80","author":"Teichmann","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00006250-200604001-00027","article-title":"Comparative trial of continuous-use and 21-day cyclic levonorgestrel and ethinyl estradiol oral contraceptive","volume":"107","author":"Teichmann","year":"2006","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0022|cit22","unstructured":"Wyeth Study evaluating levonorgestrel and ethinyl estradiol in oral contraception http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00248963"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0023|cit23","unstructured":"Merck Sharpt Dohme Corp Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC-E2 compared to a COC containing LNG\/EE (292005) (P05765) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00511342"},{"issue":"11","key":"10.1002\/14651858.CD006033.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1600-0412.2012.01498.x","article-title":"Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate\/17beta-estradiol in comparison to levonorgestrel\/ethinylestradiol","volume":"91","author":"Sordal","year":"2012","journal-title":"Acta Obstetricia Gynecologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD006033.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0010-7824(00)00110-4","article-title":"Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns","volume":"61","author":"Kesseru","year":"2000","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD006033.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.contraception.2012.02.015","article-title":"Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density","volume":"86","author":"Berenson","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0015-0282(03)02166-6","article-title":"Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial","volume":"80","author":"Carr","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2010.07.027","article-title":"The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age","volume":"83","author":"Gai","year":"2011","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.maturitas.2005.10.007","article-title":"Longitudinal evaluation of perimenopausal bone loss: Effects of different low dose oral contraceptive preparations on bone mineral density","volume":"54","author":"Gambacciani","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0030|cit30","first-page":"666","article-title":"Effect of placebo instead of a pause in the taking of ovulation inhibitors","volume":"27","author":"Hauser","year":"1970","journal-title":"Therapeutische Umschau \/ Revue Th\u00e9rapeutique"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13625180902838828","article-title":"Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls","volume":"14","author":"Lattakova","year":"2009","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0032|cit32","unstructured":"Pfizer Inc Dep-Provera: bone mineral density and total body calcium in adolescent DP150CI users and non hormonal contraception http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00139685"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0033|cit33","unstructured":"Pfizer Inc Evaluation of bone mineral density and total body calcium in adolescent DP150CI users and non hormonal contraceptive users http:\/\/www.clinicalstudyresults.org\/documents\/company-study_2143_0.pdf"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0010-7824(02)00432-8","article-title":"Vitamin D receptor gene polymorphism and bone metabolism during low-dose oral contraceptive use in young women","volume":"67","author":"Pinter","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0035|cit35","first-page":"330","article-title":"The study on the effect of using depo medroxyprogesterone acetate for contraception on bone metabolism","volume":"21","author":"Shuzhi","year":"2000","journal-title":"Acta Academiae Medicinae Hubei"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1210\/jc.2004-0924","article-title":"Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss","volume":"90","author":"Teegarden","year":"2005","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0037|cit37","unstructured":"Teva Pharmaceutical Industries (Duramed Research) A multicenter study to evaluate the effects of DR-105 on bone mineral density in adolescent females http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00924560"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0038|cit38","unstructured":"Bonny A Drug exposure and depot medroxyprogesterone acetate (DMPA) in adolescent subjects http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01461824"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e318188d1ec","article-title":"Depot medroxyprogesterone acetate and bone effects","volume":"112","author":"Committee on Adolescent Health","year":"2008","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD006033.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2005.01.132","article-title":"Prior oral contraception and postmenopausal fracture: a Womens' Health Initiative observational cohort study","volume":"84","author":"Barad","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0042|cit42","first-page":"209","article-title":"Injectable contraceptives","volume-title":"Contraceptive Technology","author":"Bartz","year":"2011"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0043|cit43","unstructured":"Centers for Disease Control and Prevention U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 http:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr59e0528.pdf 34"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.AOG.0000134789.73663.fd","article-title":"Reproductive consequences of contraceptive failure in 19 developing countries","volume":"104","author":"Cleland","year":"2004","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(93)90254-8","article-title":"Oral contraceptive pill use and fractures in women: a prospective study","volume":"14","author":"Cooper","year":"1993","journal-title":"Bone"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001703-200310000-00002","article-title":"Bone mineral density in adolescent and young adult women on injectable or oral contraception","volume":"15","author":"Cromer","year":"2003","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD006033.pub5-BIB0047|cit47","first-page":"569","article-title":"Spinal bone density in women using depot medroxyprogesterone contraception","volume":"92","author":"Cundy","year":"1998","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0048|cit48","unstructured":"U.S. Food Drug Administration Safety. Depo-Provera (medroxyprogesterone acetate injectable suspension) http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm154784.htm"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0049|cit49","unstructured":"U.S. Food Drug Administration Drugs@FDA: FDA Approved Drug Products. Depo-Provera. Label and Approval History http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Label_ApprovalHistory"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archinte.164.6.603","article-title":"Clinical considerations in premenopausal osteoporosis","volume":"164","author":"Gourlay","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006033.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.fertnstert.2009.12.054","article-title":"Surrogate end points in women's health research: science, protoscience, and pseudoscience","volume":"93","author":"Grimes","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.contraception.2008.10.016","article-title":"The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health","volume":"79","author":"Guilbert","year":"2009","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD006033.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD006033.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.2009.03688.x","article-title":"The effects of hormonal contraceptives on bone turnover markers and bone health","volume":"72","author":"Herrmann","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0055|cit55","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Howe TE Shea B Dawson LJ Downie F Murray A Ross C Exercise for preventing and treating osteoporosis in postmenopausal women Cochrane Database of Systematic Reviews 2011 CD000333","DOI":"10.1002\/14651858.CD000333.pub2"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2011.01.009","article-title":"Removing the black box warning for depot medroxyprogesterone acetate","volume":"84","author":"Kaunitz","year":"2011","journal-title":"Contraception"},{"issue":"8","key":"10.1002\/14651858.CD006033.pub5-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009849.pub2","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","author":"Lopez","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.contraception.2011.08.003","article-title":"The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception","volume":"85","author":"Mansour","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2006.01.003","article-title":"Combined hormonal contraception and bone health: a systematic review","volume":"73","author":"Martins","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Meier C Brauchli YB Jick SS Kraenzlin ME Meier CR Use of depot medroxyprogesterone acetate and fracture risk Journal of Clinical Endocrinology and Metabolism 2010 4909 16","DOI":"10.1210\/jc.2010-0032"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.contraception.2010.11.019","article-title":"Is the oral contraceptive pill associated with fracture in later life? New evidence from the Royal College of General Practitioners Oral Contraception Study","volume":"84","author":"Memon","year":"2011","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.contraception.2012.04.009","article-title":"Hormonal contraception and bone metabolism: a systematic review","volume":"86","author":"Nappi","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0064|cit64","unstructured":"Osteoporosis Prevention, Diagnosis, and Therapy NIH Consensus Statement 2000 March 27-29 2000 1 45"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0065|cit65","doi-asserted-by":"crossref","unstructured":"Rachner TD Khosla S Hofbauer LC Osteoporosis: now and the future Lancet 2011 1276 87","DOI":"10.1016\/S0140-6736(10)62349-5"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0067|cit67","first-page":"233","article-title":"Bone mineral density in women using depot medroxyprogesterone acetate for contraception","volume":"93","author":"Scholes","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0068|cit68","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Strauss","year":"2005"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0070|cit70","unstructured":"United Nations Department of Economic and Social Affairs Population Division World Contraceptive Use 2011 http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2011\/wallchart_front.pdf"},{"issue":"8","key":"10.1002\/14651858.CD006033.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/CCLM.2011.602","article-title":"International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis","volume":"49","author":"Vasikaran","year":"2011","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006033.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0010-7824(98)00026-2","article-title":"Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study","volume":"57","author":"Vessey","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.contraception.2006.01.006","article-title":"Oral contraceptive use and risk of fracture","volume":"73","author":"Vestergaard","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/13625187.2012.692411","article-title":"Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review","volume":"17","author":"Warholm","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.contraception.2006.01.002","article-title":"WHO statement on hormonal contraception and bone health","volume":"73","author":"World Health Organization","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub5-BIB0077|cit77","unstructured":"World Health Organization Medical Eligibility Criteria for Contraceptive Use. Fourth Edition, 2009 http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/9789241563888\/en\/index.html 45"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006033.pub5\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T19:37:26Z","timestamp":1716665846000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006033.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,24]]},"references-count":77,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006033.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,24]]}}}